These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 3809521)

  • 1. The effect of a putative antidepressant, an O2-substituted derivative of barbitone on apomorphine induced hypomotility.
    Menez JF; Leonard BE
    Prog Neuropsychopharmacol Biol Psychiatry; 1986; 10(6):703-8. PubMed ID: 3809521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isopropyl substitution on barbiturate ring: effects on 'open field' and 'hole board' behaviour and on biogenic amines concentrations in discrete regions of the rat brain after acute and chronic administration.
    Ménez JF; Leonard BE
    Neuropsychobiology; 1986; 15(2):95-100. PubMed ID: 3762905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A barbital derivative as an atypical antidepressant drug in mice.
    Bourin M; Menez JF; Colombel MC; Larousse C
    Arzneimittelforschung; 1987 May; 37(5):506-9. PubMed ID: 3619970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic antidepressant drug treatment attenuates motor-suppressant effects of apomorphine without changing [3H]GBR 12935 binding.
    Allison K; Paetsch PR; Baker GB; Greenshaw AJ
    Eur J Pharmacol; 1993 Nov; 249(2):125-31. PubMed ID: 8287894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on the participation of the dopaminergic system in the central effects of chronically administered antidepressant drugs.
    Kozyrska C; Zebrowska-Lupina I
    Pol J Pharmacol Pharm; 1983; 35(2):115-26. PubMed ID: 6684769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of cholecystokinin on apomorphine-induced changes of motility in rats.
    Katsuura G; Itoh S; Rehfeld JF
    Neuropharmacology; 1984 Jul; 23(7A):731-4. PubMed ID: 6089021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A 2-amino-2-oxazoline derivative as an antidepressant in mice.
    Bourin M; Creuzet MH; Jarry C; Colombel MC
    Arzneimittelforschung; 1988 May; 38(5):666-8. PubMed ID: 3261982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Barbitone-induced tolerance to the effects of sedative-hypnotics and related compounds on operant behaviour in the rat.
    Carney JM; Rosecrans JA; Vasko MR
    Br J Pharmacol; 1979 Feb; 65(2):183-92. PubMed ID: 760896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serotonin and antidepressant drugs antagonize melatonin-induced behavioural changes after injection into the nucleus accumbens of rats.
    Gaffori O; Van Ree JM
    Neuropharmacology; 1985 Mar; 24(3):237-44. PubMed ID: 2859542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Behavioural and neurochemical studies on apomorphine-induced hypomotility in mice.
    Sumners C; de Vries JB; Horn AS
    Neuropharmacology; 1981 Dec; 20(12A):1203-8. PubMed ID: 7322296
    [No Abstract]   [Full Text] [Related]  

  • 11. Antidepressant treatments: effects in rodents on dose-response curves of 5-hydroxytryptamine- and dopamine-mediated behaviours and 5-HT2 receptor number in frontal cortex.
    Green AR; Heal DJ; Johnson P; Laurence BE; Nimgaonkar VL
    Br J Pharmacol; 1983 Oct; 80(2):377-85. PubMed ID: 6606460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Time-dependent effects of antidepressant drugs on the low dose of apomorphine-induced locomotor hypoactivity in rats.
    Dziedzicka-Wasylewska M; Rogóz Z
    Pol J Pharmacol; 1997; 49(5):337-43. PubMed ID: 9566033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in rat dopamine- and serotonin function in vivo after prolonged administration of the specific 5-HT uptake inhibitor, citalopram.
    Arnt J; Overø KF; Hyttel J; Olsen R
    Psychopharmacology (Berl); 1984; 84(4):457-65. PubMed ID: 6441945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential antidepressant activity and enhancement of serotonin uptake of a new dibenzothiadiazepine derivative.
    Borsini F; Volterra G; Lecci A; Evangelista S; Mancinelli A; Cutrufo C; Parlani M; Mennini T; Barone D; Meli A
    Arzneimittelforschung; 1991 Jun; 41(6):573-80. PubMed ID: 1718290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regional biosynthesis of acetylcholine in brain following forced oral chronic barbitone treatment to rat.
    Nordberg A; Wahlström G
    J Neurochem; 1979 Feb; 32(2):371-8. PubMed ID: 762554
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of p-chlorophenylalanine on the acquisition of tolerance to barbital.
    Lê AD; Khanna JM; Kalant H; LeBlanc AE
    Can J Physiol Pharmacol; 1980 Jan; 58(1):12-6. PubMed ID: 6445772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered response to apomorphine in 6-hydroxydopamine-treated rats.
    Schoenfeld R; Uretsky N
    Eur J Pharmacol; 1972 Jul; 19(1):115-8. PubMed ID: 5048659
    [No Abstract]   [Full Text] [Related]  

  • 18. Behavioral concomitants of regional changes in the brain's biogenic amines after apomorphine and amphetamine.
    Schwarting RK; Huston JP
    Pharmacol Biochem Behav; 1992 Apr; 41(4):675-82. PubMed ID: 1594634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic antidepressant treatment increases the apomorphine-induced elevation of plasma corticosterone in rats.
    Kourkoubas A; Pitoulis S; Spyraki C
    J Pharm Pharmacol; 1988 Jun; 40(6):451-2. PubMed ID: 2901482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Change in sensitivity to halothane in the rat following administration of sodium barbitone in the drinking water [proceedings].
    Turnbull MJ; Watkins JW
    Br J Pharmacol; 1976 Oct; 58(2):285P-286P. PubMed ID: 974405
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.